|
GINS3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.377000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.985800E-01 |
| Normal-vs-Stage2 |
9.629200E-01 |
| Normal-vs-Stage3 |
7.618400E-01 |
| Normal-vs-Stage4 |
1.859420E-01 |
| Stage1-vs-Stage2 |
4.320200E-01 |
| Stage1-vs-Stage3 |
1.717790E-01 |
| Stage1-vs-Stage4 |
3.867700E-02 |
| Stage2-vs-Stage3 |
8.525200E-01 |
| Stage2-vs-Stage4 |
3.204400E-01 |
| Stage3-vs-Stage4 |
3.030200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.779800E-01 |
| Normal-vs-AfricanAmerican |
6.129000E-01 |
| Normal-vs-Asian |
1.433630E-01 |
| Caucasian-vs-AfricanAmerican |
3.784600E-01 |
| Caucasian-vs-Asian |
2.208800E-01 |
| AfricanAmerican-vs-Asian |
1.443810E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.329000E-01 |
| Normal-vs-Female |
8.650600E-01 |
| Male-vs-Female |
5.464200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.249200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.802000E-01 |
| Normal-vs-Age(61-80Yrs) |
7.362600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.205000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.469800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.322390E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.423000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.710000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.457800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.688400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.512600E-01 |
| Classical-VS-Follicular |
2.781500E-03 |
| Classical-VS-Other |
8.910400E-01 |
| Classical-VS-Normal |
2.756600E-01 |
| Tall-VS-Follicular |
7.455700E-03 |
| Tall-VS-Other |
7.443200E-01 |
| Tall-VS-Normal |
9.693600E-02 |
| Follicular-VS-Other |
2.640200E-01 |
| Follicular-VS-Normal |
1.099170E-01 |
| Other-VS-Normal |
6.869800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.637800E-01 |
| Normal-vs-N1 |
5.771200E-01 |
| N0-vs-N1 |
3.378800E-01 |
|
|
